New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer
Sunday, October 10, 2010 - 09:20
in Health & Medicine
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with...